COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2582: Articles 25811-25820  | Next

Structural basis of a public antibody response to SARS-CoV-2
Yuan, M., Liu, H., Wu, N. C., Lee, C.-C. D., Zhu, X., Zhao, F., Huang, D., Yu, W., Hua, Y., Tien, H., Rogers, T. F., Landais, E., Sok, D., Jardine, J. G., Burton, D. R., Wilson, I. A.
10.1101/2020.06.08.141267 — Posted: 2020-06-09
Molecular modelling predicts SARS-CoV-2 ORF8 protein and human complement Factor 1 catalytic domain sharing common binding site on complement C3b
Singh, J., Kar, S., Ganguly, S., Hasnain, S. E.
10.1101/2020.06.08.107011 — Posted: 2020-06-09
The hypothalamus as a hub for putative SARS-CoV-2 brain infection
Nampoothiri, S., Sauve, F., Ternier, G., Fernandois, D., Coelho, C., Imbernon, M., Deligia, E., Perbet, R., Florent, V., Baroncini, M., Pasquier, F., Trottein, F., Maurage, C.-A., Mattot, V., Giacobini, P., Rasika, S., Prevot, V.
10.1101/2020.06.08.139329 — Posted: 2020-06-09 Discussion: Onsite
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Schmidt, F., Weisblum, Y., Muecksch, F., Hoffmann, H.-H., Michailidis, E., Lorenzi, J. C. C., Mendoza, P., Rutkowska, M., Bednarski, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Caskey, M., Robbiani, D. F., Nussenzweig, M. C., Rice, C. M., Hatziioannou, T., Bieniasz, P. D.
10.1101/2020.06.08.140871 — Posted: 2020-06-09 Discussion: Onsite | Offsite
Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma
Salazar, E., Kuchipudi, S. V., Christensen, P. A., Eagar, T. N., Yi, X., Zhao, P., Jin, Z., Long, S. W., Olsen, R. J., Chen, J., Castillo, B., Leveque, C., Towers, D. M., Lavinder, J., Gollihar, J. D., Cardona, J., Ippolito, G. C., Nissly, R. H., Bird, I. M., Greenawalt, D., Rossi, R. M., Gontu, A., Srinivasan, S., Poojary, I. B., Cattadori, I. M., Hudson, P. J., Joselyn, N., Prugar, L., Huie, K., Herbert, A., Bernard, D. W., Dye, J., Kapur, V., Musser, J. M.
10.1101/2020.06.08.138990 — Posted: 2020-06-09
Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes
Takahashi, T., Wong, P., Ellingson, M., Lucas, C., Klein, J., Israelow, B., Silva, J., Oh, J., Mao, T., Tokuyama, M., Lu, P., Venkataraman, A., Park, A., Liu, F., Meir, A., Sun, J., Wang, E., Wyllie, A. L., Vogels, C. B. F., Earnest, R., Lapidus, S., Ott, I., Moore, A., Casanovas, A., Dela Cruz, C., Fournier, J., Odio, C., Farhadian, S., Grubaugh, N., Schultz, W., Ko, A., Ring, A., Omer, S., Iwasaki, A., Yale IMPACT research team
10.1101/2020.06.06.20123414 — Posted: 2020-06-09 Discussion: Onsite
SARS-CoV-2 virus and antibodies in front-line Health Care Workers in an acute hospital in London: preliminary results from a longitudinal study
Houlihan, C., Vora, N., Byrne, T., Lewer, D., Heaney, J., Moore, D. A., Matthews, R., Adam, S., Enfield, L., Severn, A., McBride, A., Spyer, M. J., Beale, R., Cherepanov, P., Gaertner, K., Shahmanesh, M., The SAFER Field Study Team, , Ng, K., Cornish, G., Walker, N., Michie, S., Manley, E., Lorencatto, F., The Crick-COVID-Consortium, , Gilson, R., Gandhi, S., Gamblin, S., Kassiotis, G., McCoy, L., Swanton, C., Hayward, A., Nastouli, E.
10.1101/2020.06.08.20120584 — Posted: 2020-06-09
Exploring the correlation between COVID-19 fatalities and poor WASH (Water, Sanitation and Hygiene) services
Amankwaa, G., Fischer, C.
10.1101/2020.06.08.20125864 — Posted: 2020-06-09
The 'Icarus effect' of preventative health behaviors
Carrignon, S., Bentley, R. A., Silk, M., Fefferman, N. H.
10.1101/2020.06.08.20126029 — Posted: 2020-06-09
Does susceptibility to novel coronavirus (COVID-19) infection differ by age?: Insights from mathematical modelling
Omori, R., Matsuyama, R., Nakata, Y.
10.1101/2020.06.08.20126003 — Posted: 2020-06-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).